Literature DB >> 21168496

Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice.

B Winner1, H L Melrose, C Zhao, K M Hinkle, M Yue, C Kent, A T Braithwaite, S Ogholikhan, R Aigner, J Winkler, M J Farrer, F H Gage.   

Abstract

The generation and maturation of adult neural stem/progenitor cells are impaired in many neurodegenerative diseases, among them is Parkinson's disease (PD). In mammals, including humans, adult neurogenesis is a lifelong feature of cellular brain plasticity in the hippocampal dentate gyrus (DG) and in the subventricular zone (SVZ)/olfactory bulb system. Hyposmia, depression, and anxiety are early non-motor symptoms in PD. There are parallels between brain regions associated with non-motor symptoms in PD and neurogenic regions. In autosomal dominant PD, mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are frequent. LRRK2 homologs in non-vertebrate systems play an important role in chemotaxis, cell polarity, and neurite arborization. We investigated adult neurogenesis and the neurite development of new neurons in the DG and SVZ/olfactory bulb system in bacterial artificial chromosome (BAC) human Lrrk2 G2019S transgenic mice. We report that mutant human Lrrk2 is highly expressed in the hippocampus in the DG and the SVZ of adult Lrrk2 G2019S mice. Proliferation of newly generated cells is significantly decreased and survival of newly generated neurons in the DG and olfactory bulb is also severely impaired. In addition, after stereotactic injection of a GFP retrovirus, newly generated neurons in the DG of Lrrk2 G2019S mice exhibited reduced dendritic arborization and fewer spines. This loss in mature, developed spines might point towards a decrease in synaptic connectivity. Interestingly, physical activity partially reverses the decrease in neuroblasts observed in Lrrk2 G2010S mice. These data further support a role for Lrrk2 in neuronal morphogenesis and provide new insights into the role of Lrrk2 in adult neurogenesis. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168496      PMCID: PMC3059106          DOI: 10.1016/j.nbd.2010.12.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  64 in total

1.  Lrrk2 localization in the primate basal ganglia and thalamus: a light and electron microscopic analysis in monkeys.

Authors:  H Lee; H L Melrose; M Yue; Jean-Francois Pare; M J Farrer; Y Smith
Journal:  Exp Neurol       Date:  2010-05-17       Impact factor: 5.330

2.  Discovery of a proneurogenic, neuroprotective chemical.

Authors:  Andrew A Pieper; Shanhai Xie; Emanuela Capota; Sandi Jo Estill; Jeannie Zhong; Jeffrey M Long; Ginger L Becker; Paula Huntington; Shauna E Goldman; Ching-Han Shen; Maria Capota; Jeremiah K Britt; Tiina Kotti; Kerstin Ure; Daniel J Brat; Noelle S Williams; Karen S MacMillan; Jacinth Naidoo; Lisa Melito; Jenny Hsieh; Jef De Brabander; Joseph M Ready; Steven L McKnight
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

3.  Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17.

Authors:  Kathrin Reetz; Rebekka Lencer; Johannes M Hagenah; Christian Gaser; Vera Tadic; Uwe Walter; Alexander Wolters; Susanne Steinlechner; Christine Zühlke; Katja Brockmann; Christine Klein; Arndt Rolfs; Ferdinand Binkofski
Journal:  Cerebellum       Date:  2010-06       Impact factor: 3.847

4.  Exercise increases BDNF levels in the striatum and decreases depressive-like behavior in chronically stressed rats.

Authors:  Lelanie Marais; Dan J Stein; Willie M U Daniels
Journal:  Metab Brain Dis       Date:  2009-10-21       Impact factor: 3.584

5.  Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis.

Authors:  Loukia Parisiadou; Chengsong Xie; Hyun Jin Cho; Xian Lin; Xing-Long Gu; Cai-Xia Long; Evy Lobbestael; Veerle Baekelandt; Jean-Marc Taymans; Lixin Sun; Huaibin Cai
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

6.  MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2.

Authors:  Cindy H Hsu; Diane Chan; Elisa Greggio; Shamol Saha; Maria D Guillily; Andrew Ferree; Kesav Raghavan; Grace C Shen; Lilach Segal; Hoon Ryu; Mark R Cookson; Benjamin Wolozin
Journal:  J Neurochem       Date:  2010-01-07       Impact factor: 5.372

7.  Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.

Authors:  Yanping Li; Wencheng Liu; Tinmarla F Oo; Lei Wang; Yi Tang; Vernice Jackson-Lewis; Chun Zhou; Kindiya Geghman; Mikhail Bogdanov; Serge Przedborski; M Flint Beal; Robert E Burke; Chenjian Li
Journal:  Nat Neurosci       Date:  2009-06-07       Impact factor: 24.884

8.  Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway.

Authors:  Iria Carballo-Carbajal; Susanne Weber-Endress; Giorgio Rovelli; Diane Chan; Benjamin Wolozin; Christian L Klein; Nadja Patenge; Thomas Gasser; Philipp J Kahle
Journal:  Cell Signal       Date:  2010-01-13       Impact factor: 4.315

9.  Expression of ezrin radixin moesin proteins in the adult subventricular zone and the rostral migratory stream.

Authors:  A Persson; C Lindwall; M A Curtis; H G Kuhn
Journal:  Neuroscience       Date:  2010-01-28       Impact factor: 3.590

10.  Inhibition of PI3K-Akt signaling blocks exercise-mediated enhancement of adult neurogenesis and synaptic plasticity in the dentate gyrus.

Authors:  Elodie Bruel-Jungerman; Alexandra Veyrac; Franck Dufour; Jennifer Horwood; Serge Laroche; Sabrina Davis
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more
  88 in total

1.  Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders.

Authors:  Jenna M Puccini; Daniel F Marker; Tim Fitzgerald; Justin Barbieri; Christopher S Kim; Patrick Miller-Rhodes; Shao-Ming Lu; Stephen Dewhurst; Harris A Gelbard
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

Review 2.  Role of LRRK2 kinase dysfunction in Parkinson disease.

Authors:  Azad Kumar; Mark R Cookson
Journal:  Expert Rev Mol Med       Date:  2011-06-13       Impact factor: 5.600

3.  Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein.

Authors:  Dong Hwan Ho; Wongi Seol; Ilhong Son
Journal:  Cell Cycle       Date:  2019-02-06       Impact factor: 4.534

4.  Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents.

Authors:  Andrew B West; Rita M Cowell; João P L Daher; Mark S Moehle; Kelly M Hinkle; Heather L Melrose; David G Standaert; Laura A Volpicelli-Daley
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

Review 5.  The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.

Authors:  J Schapansky; J D Nardozzi; M J LaVoie
Journal:  Neuroscience       Date:  2014-10-02       Impact factor: 3.590

Review 6.  ADULT NEUROGENESIS IN HUMANS: A Review of Basic Concepts, History, Current Research, and Clinical Implications.

Authors:  Ashutosh Kumar; Vikas Pareek; Muneeb A Faiq; Sanjib K Ghosh; Chiman Kumari
Journal:  Innov Clin Neurosci       Date:  2019-05-01

7.  Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1.

Authors:  Marija Cvetanovic; Yuan-Shih Hu; Puneet Opal
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

Review 8.  Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression.

Authors:  Jaclyn Nicole Le Grand; Laura Gonzalez-Cano; Maria Angeliki Pavlou; Jens C Schwamborn
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

9.  Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.

Authors:  Manish Verma; Jason Callio; P Anthony Otero; Israel Sekler; Zachary P Wills; Charleen T Chu
Journal:  J Neurosci       Date:  2017-10-16       Impact factor: 6.167

Review 10.  iPS cells in the study of PD molecular pathogenesis.

Authors:  Melanie M Cobb; Abinaya Ravisankar; Gaia Skibinski; Steven Finkbeiner
Journal:  Cell Tissue Res       Date:  2017-12-12       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.